COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Analyst Earnings Estimates
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 463.9M 67.53% | 566.767M 22.17% | 631.449M 11.41% | 760.7M 20.47% | 782.82M 2.91% | 728.28M -6.97% | 661.03M -9.23% | 731.03M 10.59% | 764.03M 4.51% | |
| EBITDA YoY % growth | 203.6M 116.60% | 324.717M 59.49% | 339.055M 4.42% | 445.75M 31.47% | 441.58M -0.94% | 383.21M -13.22% | 349.96M -8.68% | 350.78M 0.23% | 353.74M 0.84% | |
| EBIT YoY % growth | 69.4M 176.49% | 175.461M 152.83% | 169.895M -3.17% | 307.59M 81.05% | 278.49M -9.46% | 369.9M 32.82% | 266.62M -27.92% | N/A | N/A | |
| Operating Margin | 14.96% | 30.96% | 26.91% | 40.44% | 35.58% | 50.79% | 40.33% | N/A | N/A | |
| EPS YoY % growth | 0.56 43.59% | 1.18 110.71% | 6.45 446.61% | 7.03 8.96% | 7.16 1.90% | 6.26 -12.64% | 6.41 2.39% | 9.34 45.86% | 9.53 1.97% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 1.65 1.79% | 1.83 13.83% | 2.03 14.60% | 1.62 8.50% |
| Revenue Q2Q % growth | 184.5M 27.00% | 192.94M 21.12% | 198.04M 8.84% | 187.39M 5.42% |
| EBITDA Q2Q % growth | 105.75M -10.66% | 114.92M -22.08% | 118.95M -42.61% | 107.73M 37.67% |
| EBIT Q2Q % growth | 71.262M 50.12% | 78.172M 124.38% | 98.359M 158.09% | 65.503M 202.04% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.49 2.76% | 1.46 | 0.03 | 1.96% |
| Q4 2024 Q2Q % growth | 1.77 115.85% | 1.57 | 0.20 | 12.85% |
| Q3 2024 Q2Q % growth | 1.61 203.77% | 1.62 | -0.01 | -0.88% |
| Q2 2024 Q2Q % growth | 1.62 376.47% | 1.51 | 0.11 | 6.95% |
| Q1 2024 Q2Q % growth | 1.45 384.31% | 0.96 | 0.49 | 51.47% |
| Q4 2023 Q2Q % growth | 0.82 490.48% | 0.67 | 0.15 | 21.81% |
| Q3 2023 Q2Q % growth | 0.53 5,200.00% | 0.53 | 0.00 | 0.57% |
| Q2 2023 Q2Q % growth | 0.34 6.25% | 0.29 | 0.05 | 15.94% |
| Q1 2023 Q2Q % growth | -0.51 -215.91% | 0.32 | -0.83 | -259.24% |
| Q4 2022 Q2Q % growth | -0.21 58.82% | -0.15 | -0.06 | -41.99% |
| Q3 2022 Q2Q % growth | 0.01 -95.45% | -0.14 | 0.15 | 107.26% |
| Q2 2022 Q2Q % growth | 0.32 18.52% | 1.45 | -1.13 | -77.95% |
| Q1 2022 Q2Q % growth | 0.44 7.32% | 0.91 | -0.47 | -51.83% |
| Q4 2021 Q2Q % growth | -0.51 -355.00% | 1.06 | -1.57 | -148.21% |
| Q3 2021 Q2Q % growth | 0.22 -31.25% | 0.97 | -0.75 | -77.34% |
| Q2 2021 Q2Q % growth | 0.27 17.39% | 0.48 | -0.21 | -43.92% |
| Q1 2021 Q2Q % growth | 0.41 4,000.00% | 0.43 | -0.02 | -4.75% |
| Q4 2020 Q2Q % growth | 0.20 385.71% | 0.40 | -0.20 | -49.51% |
| Q3 2020 Q2Q % growth | 0.32 277.78% | 0.42 | -0.10 | -23.21% |
| Q2 2020 Q2Q % growth | 0.23 264.29% | 0.31 | -0.08 | -26.07% |
| Q1 2020 Q2Q % growth | 0.01 103.45% | 0.42 | -0.41 | -97.62% |
| Q4 2019 Q2Q % growth | -0.07 | -0.09 | 0.02 | 19.93% |
| Q3 2019 Q2Q % growth | -0.18 | -0.12 | -0.06 | -48.83% |
| Q2 2019 Q2Q % growth | -0.14 | -0.18 | 0.04 | 20.60% |
| Q1 2019 Q2Q % growth | -0.29 | -0.24 | -0.05 | -22.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 177.757M 22.66% | 175.4M | 2.357M | 1.34% |
| Q4 2024 Q2Q % growth | 181.949M 21.51% | 183.39M | -1.441M | -0.79% |
| Q3 2024 Q2Q % growth | 159.301M 16.52% | 158.69M | 611K | 0.39% |
| Q2 2024 Q2Q % growth | 145.276M 7.18% | 146.82M | -1.544M | -1.05% |
| Q1 2024 Q2Q % growth | 144.923M 0.11% | 149.79M | -4.867M | -3.25% |
| Q4 2023 Q2Q % growth | 149.745M 15.54% | 150.78M | -1.035M | -0.69% |
| Q3 2023 Q2Q % growth | 136.71M 7.65% | 141.03M | -4.32M | -3.06% |
| Q2 2023 Q2Q % growth | 135.546M 9.75% | 141.17M | -5.624M | -3.98% |
| Q1 2023 Q2Q % growth | 144.767M 72.75% | 141.24M | 3.527M | 2.50% |
| Q4 2022 Q2Q % growth | 129.6M 372.99% | 127.7M | 1.9M | 1.49% |
| Q3 2022 Q2Q % growth | 127M 61.17% | 126.82M | 180K | 0.14% |
| Q2 2022 Q2Q % growth | 123.5M 48.97% | 124.09M | -590K | -0.48% |
| Q1 2022 Q2Q % growth | 83.8M -4.45% | 80.461M | 3.339M | 4.15% |
| Q4 2021 Q2Q % growth | 27.4M -64.09% | 83.24M | -55.84M | -67.08% |
| Q3 2021 Q2Q % growth | 78.8M -0.51% | 86.589M | -7.789M | -9.00% |
| Q2 2021 Q2Q % growth | 82.9M 6.15% | 86.468M | -3.568M | -4.13% |
| Q1 2021 Q2Q % growth | 87.7M 14.64% | 83.503M | 4.197M | 5.03% |
| Q4 2020 Q2Q % growth | 76.3M 2.83% | 78.955M | -2.655M | -3.36% |
| Q3 2020 Q2Q % growth | 79.2M 8.64% | 78.977M | 223K | 0.28% |
| Q2 2020 Q2Q % growth | 78.1M 4.13% | 75.893M | 2.207M | 2.91% |
| Q1 2020 Q2Q % growth | 76.5M 2.68% | 78.21M | -1.71M | -2.19% |
| Q4 2019 Q2Q % growth | 74.2M | 74.799M | -599K | -0.80% |
| Q3 2019 Q2Q % growth | 72.9M | 75.809M | -2.909M | -3.84% |
| Q2 2019 Q2Q % growth | 75M | 77.34M | -2.34M | -3.03% |
| Q1 2019 Q2Q % growth | 74.5M | 72.233M | 2.267M | 3.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.57% | -0.68% | -11.85% | -0.25% |
| Revenue | -1.02% | -0.69% | 0.36% | 0.43% |